Abstract |
|
Authors | Koichi Sakabe, Nobuo Fukuda, Katsunori Wakayama, Teru Nada, Hisanori Shinohara, Yoshiyuki Tamura |
Journal | The American journal of cardiology
(Am J Cardiol)
Vol. 94
Issue 4
Pg. 497-500
(Aug 15 2004)
ISSN: 0002-9149 [Print] United States |
PMID | 15325939
(Publication Type: Journal Article)
|
Chemical References |
- Anticholesteremic Agents
- Cholesterol, HDL
- Cholesterol, LDL
- Heptanoic Acids
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Plasminogen Activator Inhibitor 1
- Pyrroles
- Thiobarbituric Acid Reactive Substances
- Triglycerides
- Cholesterol
- Atorvastatin
|
Topics |
- Adult
- Aged
- Anticholesteremic Agents
(adverse effects, therapeutic use)
- Atorvastatin
- Basilar Artery
(drug effects)
- Cholesterol
(blood)
- Cholesterol, HDL
(blood)
- Cholesterol, LDL
(blood)
- Endothelium, Vascular
(drug effects)
- Female
- Fibrinolysis
(drug effects)
- Follow-Up Studies
- Heptanoic Acids
(adverse effects, therapeutic use)
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(adverse effects, therapeutic use)
- Hypercholesterolemia
(blood, drug therapy)
- Long-Term Care
- Male
- Middle Aged
- Plasminogen Activator Inhibitor 1
(blood)
- Prospective Studies
- Pyrroles
(adverse effects, therapeutic use)
- Thiobarbituric Acid Reactive Substances
(metabolism)
- Treatment Outcome
- Triglycerides
(blood)
- Vasodilation
(drug effects)
|